SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001308179-20-000231
Filing Date
2020-04-28
Accepted
2020-04-28 16:33:51
Documents
4
Effectiveness Date
2020-04-28

Document Format Files

Seq Description Document Type Size
1 VERTEX PHARMACEUTICALS INC - DEFA14A lvrtx2020_defa14a.htm DEFA14A 20644
2 GRAPHIC box1.jpg GRAPHIC 1088
3 GRAPHIC check1.jpg GRAPHIC 1465
4 GRAPHIC lvrtx1x1.jpg GRAPHIC 10557
  Complete submission text file 0001308179-20-000231.txt   40069
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-19319 | Film No.: 20825596
SIC: 2834 Pharmaceutical Preparations